Sensory Integration for Infants With Cortical Visual Impairment
The Effectiveness of Sensory Integration Interventions on Motor and Sensory Functions in Infants With Cortical Vision Impairment and Cerebral Palsy: A Single Blind Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Çankaya
-
Ankara, Çankaya, Turkey, 06530
- Occupational Therapy Department
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Cerepral palsy
- Cortical visual impairment
- 12-18 months
Exclusion Criteria
- Not participating in treatment regularly
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: İntervention group: Physiotherapy and Sensory Integration Therapy
Physiotherapy program 8 weeks 2 days in a week 45 minutes per session Conventional physiotherapy Sensory integration therapy program 8 weeks 2 days in a week 45 minutes per session Sensory integration therapy |
The individuals were divided into two as randomized controlled.
Both physiotherapy and sensory integration therapy were applied to the intervention group.
Each treatment was applied as 2 sessions per week, 2 days a week for 8 weeks.
In the control group, only physiotherapy treatment was applied for 8 weeks, 2 days a week, 2 sessions per week.
|
|
ACTIVE_COMPARATOR: Control group only Physiotherapy
Physiotherapy program 8 weeks 2 days in a week 45 minutes per session Conventional physiotherapy |
The individuals were divided into two as randomized controlled.
Both physiotherapy and sensory integration therapy were applied to the intervention group.
Each treatment was applied as 2 sessions per week, 2 days a week for 8 weeks.
In the control group, only physiotherapy treatment was applied for 8 weeks, 2 days a week, 2 sessions per week.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Test of Sensory Functions in Infants (TSFI)
Time Frame: 30 minute
|
The TSFI consists of 24 items.
It was developed to evaluate sensory processing problems in infants aged 4 to 18 months.
The test consists of five subsections and 24 items.
|
30 minute
|
|
Alberta Infant Motor Scale (AIMS)
Time Frame: 30 minute
|
The AIMS gives information about the gross motor development of infants whose corrected ages are between 0 and 18 months.
In AIMS, the age of infants is calculated as the corrected age.
It allows the family and the clinician to obtain information about the infant's current motor development and to compare the motor development before and after treatment.
|
30 minute
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Test of Sensory Functions in Infants (TSFI)
Time Frame: 30 minute
|
The TSFI consists of 24 items.
It was developed to evaluate sensory processing problems in infants aged 4 to 18 months.
The test consists of five subsections and 24 items.
|
30 minute
|
|
Alberta Infant Motor Scale (AIMS)
Time Frame: 30 minute
|
The AIMS gives information about the gross motor development of infants whose corrected ages are between 0 and 18 months.
In AIMS, the age of infants is calculated as the corrected age.
It allows the family and the clinician to obtain information about the infant's current motor development and to compare the motor development before and after treatment.
|
30 minute
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: mustafa cemali, Phd. student, Hacettepe Universitesi
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2020-20/494
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.